Unknown PHASE3 INTERVENTIONAL 2-arm NCT02957266

Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy (CERVIPIB)

Improvement of Locally Advanced Cervical Cancer Radiotherapy Efficacy by Use of Volumetric Arc Therapy, Individualized Polyradiosensitization and Interstitial Brachytherapy

Sponsor: The National Center of Oncology, Azerbaijan

Conditions Cervical Cancer

Interventions BRAF Cisplatin Gemcitabine Interstitial brachytherapy KRAS PIK3CA RRM1 Volumetric Arc Radiotherapy

Updated 6 times since 2017 Last updated: Nov 14, 2016 Started: Mar 31, 2015 Primary completion: Dec 31, 2018 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Cervical Cancer, this trial is ongoing. The trial is conducted by The National Center of Oncology, Azerbaijan and has accumulated 6 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jun 2018 — Jan 2021 [monthly]

Recruiting PHASE3
Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE3

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The National Center of Oncology, Azerbaijan

Data source: The National Center of Oncology, Azerbaijan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baku, Azerbaijan